Showing 14 posts of 59 posts found.


Gilead gets FDA nod for revolutionary blood cancer treatment

October 19, 2017
Sales and Marketing CAR-T, Gilead, Yescarta, biotech, drugs, pharma, pharmaceutical

Only weeks after Gilead announced the completion of Kite, it got the news it was hoping for with the FDA’s …


Gilead completes £11.9 billion Kite Pharma acquisition

October 5, 2017
Sales and Marketing CAR T, CAR-T, Gilead, Kite, acquisition, pharma, pharmaceuticals

Gilead has announced that it has completed its acquisition of Kite Pharma after the deal was announced on 28 August …

FDA halts trial after first CAR T-associated patient death

September 6, 2017
Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical

French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …


Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017
Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …


CAR-T treatment is given ‘historic’ first approval by FDA

August 31, 2017
Research and Development, Sales and Marketing CAR-T, Kymriah, Novartis, biotech, drugs, pharma, pharmaceutical

Novartis has received approval for its CAR-T treatment of paediatric and young adults with a form of acute lymphoblastic leukaemia …


New research reports first-ever response of central nervous tumour to CAR T therapy

August 29, 2017
Manufacturing and Production, Research and Development CAR T, CAR-T, Cancer, life sciences, lymphoma, medicine, pharma, pharmaceuticals

Researchers at a General Hospital in Massachusetts has reported what they claim is the first response of a nervous system …

Novartis’ breakthrough cancer treatment receives FDA advisory approval

July 13, 2017
Research and Development, Sales and Marketing CAR-T, FDA, Novartis, biotech, drugs, pharma, pharmaceutical

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …

Unprecedented CAR-T data shows 100% response rate

June 7, 2017
Research and Development ASCO, CAR T, CAR-T

Researchers celebrated a world-first at the American Society of Clinical Oncology conference, revealing data which showed that, in a study …


Novartis posts 82% remission rate in CAR T paediatric study

December 5, 2016
Research and Development, Sales and Marketing CAR T, CAR-T, Novartis, leukaemia, paediatric

Novartis has released the results of its global, paediatric study of the treatment of leukaemia in children and young adults …


Up to 120 jobs set to go as Novartis closes down Cell and Gene Therapies unit

September 1, 2016
Manufacturing and Production, Research and Development CAR-T, Novartis, cart, cell and gene therapies

News has emerged that Novartis plans to close down its Cell and Gene Therapies unit, with up to 120 workers …


Researchers launch CAR-T cell therapy trial in head and neck cancer

December 9, 2015
Research and Development CAR-T, CAR-T therapy, Cancer, head and neck cancers, oncology R&D

A pioneering trial is beginning in London, where doctors are harnessing patients’ own immune systems to find a new effective …


Kite Pharma says trial death was unrelated to KTE-C19

August 18, 2015
Medical Communications, Research and Development CAR-T, cinical trials, kite pharma, non-Hodgkin's lymphoma, non-Hodgkin’s lymphoma

Kite has confirmed last week’s rumours that a patient had died during its Phase I/II trial for the KTE-C19 non-Hodgkin’s …


Celgene enters 10-year $1 billion pact with Juno

June 30, 2015
Research and Development, Sales and Marketing CAR-T, Celgene, Chimeric Antigen Receptor Technology, Juno, T Cell Receptor, TCR, brett wells

Celgene has invested $1 billion into Juno Therapeutics as part of a 10-year partnership aiming to study cures for cancer …

Latest content